nivolumab
bms
['check,mate,274', 'bms', 'scienceatbms']
don t miss late-breaking data at #ascogu23! join us on 2/17 at 2:42pm pst for an oral presentation by dr. , on 36-month median follow-up data from our checkmate-274 trial comparing #adjuvant #immunotherapy vs placebo in high-risk #miuc patients-lba#443 
Official Bristol Myers Squibb Twitter handle for science. Connecting researchers, scientists and healthcare professionals through science; guidelines below: